1055073-24-9Relevant academic research and scientific papers
Methods for treatment of renal cell carcinoma
-
, (2008/06/13)
A method of treating renal cell carcinoma in a mammal with that disease comprising administering to the mammal a physiologically effective amount of an inhibitor of PDE10.
Methods for treatment of scleroderma
-
, (2008/06/13)
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of scleroderma.
Methods for treatment of diseases where GSK 3-beta is desired, and methods to identify compounds usefule for that
-
, (2008/06/13)
A method for selecting compounds for the treatment of diseases where GSK3β is desired includes assessing whether the compounds cause an increase in PKG activity in the tissue of interest.
Methods for treatment of multiple sclerosis
-
, (2008/06/13)
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of multiple sclerosis.
Methods for treatment of lupus erythematosus
-
, (2008/06/13)
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of lupus erythematosus.
Method for treating a patient with neoplasia using Iressa
-
Page 19, (2008/06/13)
This invention provides a method for treating a patient with neoplasia by an adjuvant therapy that includes treatment with an inhibitor of human epidermal growth factor receptor tyrosine kinase and a cGMP-specific phosphodiesterase inhibitor.
Methods for treatment of cystic fibrosis
-
, (2008/06/13)
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of cystic fibrosis.
Methods for treatment of type I diabetes
-
, (2008/06/13)
Substituted condensation products of -benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of type I diabetes.
